title: Optogenetic evidence that pallidal projections, not nigral projections, from the nucleus accumbens core are necessary for reinstating cocaine seeking.
abstract: The core subcompartment of the nucleus accumbens (NAcore) contributes significantly to behavioral responses following motivationally relevant stimuli, including drug-induced, stress-induced, and cue-induced reinstatement of cocaine seeking. Projections from NAcore that could carry information necessary to initiate reinstated cocaine seeking include outputs via the indirect pathway to the dorsolateral subcompartment of the ventral pallidum (dlVP) and through the direct pathway to the medial substantia nigra (SN). Here we used an optogenetic strategy to determine whether the dlVP or nigral projections from the NAcore are necessary for cocaine seeking initiated by a cocaine and conditioned cue combination in rats extinguished from cocaine self-administration. Rats were pretreated in the NAcore with an adeno-associated virus expressing the inhibitory opsin archaerhodopsin, and fiber-optic cannulae were implanted above the indirect pathway axon terminal field in the dlVP, or the direct pathway terminal field in the SN. Inhibiting the indirect pathway to the dlVP, but not the direct pathway to the SN, prevented cocaine-plus-cue-induced reinstatement. We also examined projections back to the NAcore from the ventral tegmental area (VTA) and dlVP. Inhibiting the dlVP to NAcore projection did not alter, while inhibiting VTA afferents abolished reinstated cocaine seeking. Localization of green fluorescent protein reporter expression and whole-cell patch electrophysiology were used to verify opsin expression. These data reveal a circuit involving activation of VTA inputs to the NAcore and NAcore projections through the indirect pathway to the dlVP as critical for cocaine-plus-cue-induced reinstatement of cocaine seeking.
authors: Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA.
authors: Michael T
authors: MT
authors: Stefanik
authors: Yonatan M
authors: YM
authors: Kupchik
authors: Robyn M
authors: RM
authors: Brown
authors: Peter W
authors: PW
authors: Kalivas
mesh_terms: D000818:Animals; D003042:Cocaine / Q000008:administration & dosage*; D003216:Conditioning, Operant / Q000502:physiology; D000229:Dependovirus / Q000502:physiology; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D058999:Drug-Seeking Behavior / Q000187:drug effects / Q000502:physiology*; D004558:Electric Stimulation; D005106:Exploratory Behavior / Q000187:drug effects; D005108:Extinction, Psychological / Q000187:drug effects; D005917:Globus Pallidus / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D066298:In Vitro Techniques; D053444:Inhibitory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D008297:Male; D009434:Neural Pathways / Q000187:drug effects* / Q000502:physiology; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology*; D055355:Opsins / Q000235:genetics / Q000378:metabolism; D062308:Optogenetics; D018408:Patch-Clamp Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D012054:Reinforcement, Psychology; D012646:Self Administration; D014161:Transduction, Genetic
chemical_list: D018765:Dopamine Uptake Inhibitors; D055355:Opsins; D049452:Green Fluorescent Proteins; D003042:Cocaine
references: Science. 1990 Dec 7;250(4986):1429-32
references: 2147780
references: J Comp Neurol. 1994 Jul 22;345(4):579-95
references: 7962701
references: J Neurosci. 2012 Sep 19;32(38):13309-26
references: 22993446
references: Nat Rev Neurosci. 2011 Oct 20;12(11):652-69
references: 22011681
references: Neuroscience. 2010 Jan 13;165(1):179-87
references: 19825396
references: Neuroscience. 1991;41(1):89-125
references: 2057066
references: Trends Neurosci. 2010 Sep;33(9):391-8
references: 20655604
references: Brain Res. 1992 May 29;581(2):344-50
references: 1393539
references: Eur J Neurosci. 2012 Feb;35(4):614-22
references: 22321070
references: Neuroscience. 2007 Feb 23;144(4):1209-18
references: 17184925
references: Nat Neurosci. 2013 May;16(5):632-8
references: 23542690
references: J Comp Neurol. 1996 Aug 05;371(4):552-66
references: 8841909
references: Annu Rev Neurosci. 2011;34:441-66
references: 21469956
references: Prog Neurobiol. 1994 Apr;42(6):719-61
references: 7938546
references: Psychopharmacology (Berl). 2001 Mar;154(3):301-10
references: 11351937
references: Neuroscience. 2003;120(3):783-98
references: 12895518
references: Neuron. 2012 Jun 7;74(5):858-73
references: 22681690
references: Nature. 2012 Dec 20;492(7429):452-6
references: 23178810
references: Neuron. 2011 Jul 14;71(1):9-34
references: 21745635
references: Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20
references: 12402102
references: J Comp Neurol. 1995 Oct 9;361(1):57-76
references: 8550882
references: Brain. 2011 Jul;134(Pt 7):2013-24
references: 21690575
references: Nat Neurosci. 2012 Jun;15(6):816-8
references: 22544310
references: Nat Protoc. 2011 Dec 08;7(1):12-23
references: 22157972
references: J Comp Neurol. 1996 Jan 08;364(2):340-62
references: 8788254
references: Brain Res. 2005 Jul 19;1050(1-2):8-14
references: 15978559
references: Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3597-602
references: 23401523
references: Nat Neurosci. 2011 Jan;14(1):22-4
references: 21131952
references: Addict Biol. 2013 Jan;18(1):50-3
references: 22823160
references: Neuron. 2012 Mar 22;73(6):1184-94
references: 22445345
references: Neuroscience. 1996 Jan;70(1):93-102
references: 8848140
references: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references: 19710631
references: Synapse. 1995 May;20(1):10-8
references: 7624824
references: Psychopharmacology (Berl). 1999 Apr;143(3):254-60
references: 10353427
references: J Neurosci Methods. 1980 Dec;3(2):129-49
references: 6110810
references: J Comp Neurol. 2010 Nov 15;518(22):4649-73
references: 20886627
references: Nat Rev Neurosci. 2009 Aug;10(8):561-72
references: 19571793
references: Neuroscience. 1998 Feb;82(3):767-80
references: 9483534
references: J Neurosci. 2001 Nov 1;21(21):8655-63
references: 11606653
references: Brain Res Bull. 1982 Jul-Dec;9(1-6):321-53
references: 6816390
references: J Pharmacol Exp Ther. 2008 May;325(2):556-66
references: 18252810
references: J Comp Neurol. 1995 May 8;355(3):418-26
references: 7636023
references: Neuropsychopharmacology. 2006 Jul;31(7):1452-61
references: 16205775
references: Nature. 2010 Jan 7;463(7277):98-102
references: 20054397
references: Neuroscience. 1989;30(1):33-50
references: 2473414
references: Eur J Neurosci. 2009 Sep;30(6):1117-27
references: 19735286
references: Eur J Neurosci. 2010 Nov;32(9):1564-72
references: 21040517
references: Brain Struct Funct. 2013 Nov;218(6):1487-500
references: 23143342
references: Psychopharmacology (Berl). 2003 Jul;168(1-2):132-138
references: 12491029
references: Neuron. 2012 Nov 21;76(4):790-803
references: 23177963
references: J Neurosci. 2010 Jun 16;30(24):8229-33
references: 20554874
references: Science. 2010 Oct 15;330(6002):385-90
references: 20947769
references: J Neurosci. 2005 May 4;25(18):4512-20
references: 15872098
references: Neuron. 2011 Feb 24;69(4):650-63
references: 21338877
references: Neuron. 2010 Mar 11;65(5):643-56
references: 20223200
references: Behav Brain Res. 2009 Jan 23;196(2):155-67
references: 18955088
references: Front Neuroanat. 2011 Jul 18;5:41
references: 21811439
references: Curr Opin Neurobiol. 2013 Aug;23(4):546-52
references: 23428656
references: Behav Brain Res. 2013 Oct 15;255:64-74
references: 23707248
references: J Comp Neurol. 1993 Jan 8;327(2):220-32
references: 8425943
references: J Comp Neurol. 1984 Mar 1;223(3):347-67
references: 6323552
references: Neuroscience. 1993 Nov;57(1):113-42
references: 8278047
references: Brain Res. 2010 Feb 16;1314:175-82
references: 19913520
references: J Neurosci. 2010 May 19;30(20):7105-10
references: 20484653
references: Am J Psychiatry. 2005 Aug;162(8):1403-13
references: 16055761
references: J Neurosci. 2004 Feb 18;24(7):1551-60
references: 14973230